Print pageHome » News: Boehringer Ingelheim Employee Bitten By Monkey
News: Boehringer Ingelheim Employee Bitten By Monkey
PharmaManufacturing.com
08/04/2011
Paramedics responded to a call from Boehringer Ingelheim regarding an employee bitten by a monkey. The USDA Animal and Plant Health Inspection Service noted in its most recent annual report (2010) that the facility held 226 non-human primates, 229 dogs and 39 guinea pigs.
Fire Chief Heather Burford said afterward that the injury was minor and that the employee was taken to the hospital. Burford said it was the first such call in more than five years.
Boehringer Ingelheim, a German pharmaceutical company, is Ridgefield's largest employer and taxpayer.
Click here for the original story.
More News:
-
05/22/2013
Novo Acquires Xellia Pharmaceuticals for $700 MillionFrom PharmaTimes Online
Novo A/S has acquired Xellia Pharmaceuticals of Norway
-
05/22/2013
Royalty Increases Bid as Elan Unveils AcquisitionsFrom PharmaTimes Online
Royalty Pharma has resurfaced to raise its bid to acquire the Irish drugmaker Elan
-
05/22/2013
New Asthma Drug Offers Hope for PatientsFrom Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough
-
05/21/2013
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
-
05/21/2013
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
-
05/21/2013
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
-
05/17/2013
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
-
05/16/2013
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
-
05/16/2013
$15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com
Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.
-
05/15/2013
Rapid Micro Biosystems Offers Workshops at New European Headquarters in MunichFrom Rapid Micro Biosystems
Company hosts hands-on demonstrations of its Growth Direct System
- All news »
Get Connected Now!
- Featured White Papers
Sponsored Links
